Bluebird Bio Inc. buy Barclays PLC
Start price
15.08.24
/
50%
€0.70
Target price
15.08.25
€3.64
Performance (%)
-47.73%
End price
16.08.25
-
Summary
This prediction is currently being closed. The BUY prediction by Barclays_PLC for Bluebird Bio Inc. is performing very badly with a performance of -47.73%. Barclays_PLC has a follow-up prediction for Bluebird Bio Inc. where he still thinks Bluebird Bio Inc. is a Buy. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bluebird Bio Inc. | - | - | - |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
Comments by Barclays_PLC for this prediction
In the thread Bluebird Bio Inc. diskutieren
bluebird bio, Inc. (NASDAQ: BLUE) had its price target lowered by analysts at Barclays PLC from $8.00 to $4.00. They now have an "overweight" rating on the stock.
Ratings data for BLUE provided by MarketBeat
In the thread Trading Bluebird Bio Inc.
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten